Soluble β-Amyloid1-40Induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses
Open Access
- 30 November 2005
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (48) , 11061-11070
- https://doi.org/10.1523/jneurosci.3034-05.2005
Abstract
Amyloid-β (Aβ) has been implicated in memory loss and disruption of synaptic plasticity observed in early-stage Alzheimer's disease. Recently, it has been shown that soluble Aβ oligomers target synapses in cultured rat hippocampal neurons, suggesting a direct role of Aβ in the regulation of synaptic structure and function. Postsynaptic density-95 (PSD-95) is a postsynaptic scaffolding protein that plays a critical role in synaptic plasticity and the stabilization of AMPA (AMPARs) and NMDA (NMDARs) receptors at synapses. Here, we show that exposure of cultured cortical neurons to soluble oligomers of Aβ1-40 reduces PSD-95 protein levels in a dose- and time-dependent manner and that the Aβ11-40-dependent decrease in PSD-95 requires NMDAR activity. We also show that the decrease in PSD-95 requires cyclin-dependent kinase 5 activity and involves the proteasome pathway. Immunostaining analysis of cortical cultured neurons revealed that Aβ treatment induces concomitant decreases in PSD-95 at synapses and in the surface expression of the AMPAR glutamate receptor subunit 2. Together, these data suggest a novel pathway by which Aβ triggers synaptic dysfunction, namely, by altering the molecular composition of glutamatergic synapses.Keywords
This publication has 66 references indexed in Scilit:
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface ExpressionJournal of Neuroscience, 2004
- A proteasome-sensitive connection between PSD-95 and GluR1 endocytosisNeuropharmacology, 2004
- Cdk5 deregulation in the pathogenesis of Alzheimer's diseaseTrends in Molecular Medicine, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivoEuropean Journal of Neuroscience, 2004
- Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2Biochemical Journal, 2004
- Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteinsJournal of Neurochemistry, 2004
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1997